Factors associated with gain in weight in women using oral contraceptives: Resulting of a French 2001 opinion poll survey conducted on 1665 women;Facteurs associés à la prise de poids chez les femmes utilisant des contraceptifs oraux: Enquête par sondage réalisée en 2001 auprès de 1665 femmes

Gynecologie Obstetrique et Fertilite

Volumn 31, Issue 3, 2003, Pages 230-239

  Le M G ^a   Laveissiere M N ^b   Pelissier C ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Hôpital Cochin ^*  (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Gain of weight; National survey; Oral contraceptives; Water retention

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; LONG TERM CARE; MASTALGIA; MENSTRUATION DISORDER; METRORRHAGIA; ORAL CONTRACEPTION; PILL; POPULATION RESEARCH; QUESTIONNAIRE; RISK FACTOR; SIDE EFFECT; SKIN DISEASE; WATER RETENTION; WEIGHT GAIN;

EID: 0038683317     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(03)00033-X     Document Type: Article

References (33)

1. Blackburn RD, Cunkelman JA, Zlidar VM. Contraceptifs oraux. Une mise à jour. Pop Reports 2000;A9:1-2.
2. Leridon H. Trente ans de contraception en France. Contraception 1998;26:435-8.
3. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
4. Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G. Mortality associated with oral contraceptive use: 25 years follow-up of cohort of 46,000 women from Royal College of General Practitioners' oral contraception study. BMJ 1999;318:96-100.
5. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and non-fatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995;346:1589-93.
6. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet 1997;349:1202-9.
7. Grubb GS. Women's perceptions of safety of the pill: a survey in 8 developping countries. J Biosocial Sci 1987;19:313-21.
8. Carpenter S, Neinstein LS. Weight gain in adolescent and young adult oral contraceptive users. F Adolescent Health Care 1986;7:342-4.
9. Fuchs N, Prinz H, Koch U. Attitudes to current oral contraceptive use and future developments: the women's perspective. Eur J Contraception Reprod Health Care 1996;1:275-84.
10. Mimoun S, Lê MG, Buhler M, Costa A, Hosansky F. Le vécu des règles et de leurs troubles chez 603 femmes sous contraception en 1999. Gynecol Obstet Fertil 2000;28:904-12.
11. Elia D. Surcharge pondérale et événements hormonaux chez la femme. Effet des contraceptifs oraux sur le poids. La lettre du Gynécologue 1997;226:15-9.
12. Laveissière MN, Pélissier C, Lê MG. La contraception orale en France en 2001: résultats d'une enquête par sondage portant sur 3609 femmes âgées de 15 à 45 ans. Gynécol Obstét Fertil 2003;31:220-9.
13. Oddens BJ, Arnolds HTh, Van Maris MGM, Van Lunsen HW. The dynamics of oral contraceptive use in the Netherlands 1990-93. Adv Contraception 1994;10:167-74.
14. Gupta S. Weight gain on the combined pill- is it real? Hum Reprod Update 2000;6(5):427-31.
15. Reckers H. Multicentre trial of a monophasic oral contraceptive containing ethinyl oestradiol and desogestrel. Acta Obstet Gynecol Scand 1988;67:171-4.
16. Wouters ZTB, Karba VD. Five-years multicentre study of triphasic low dose oral contraceptive pills. Int J Fertil 1988;33:406-10.
17. Dustenberg B, Brill K. Clinical experience with a low dose oral contraceptive containing gestodene. Adv Contracept 1990;60:37-50.
18. Brill K, Norpoth T, Schnitker J, et al. Clinical experience with a modern low dose oral contraceptive in almost 100,000 users. Contraception 1991;43:101-10.
19. Renier M, Buytaert P. Open prospective multicentre trial with a new monophasic contraceptive combination containing Gestodene. Contraception 1991;43:413-21.
20. Lammers P, Berg MOT. Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinyl oestradiol. Acta Obstet Gynecol Scand 1991;70:497-500.
21. Runnebaum B, Grunwald K, Rabe T. The efficacy and tolerability of norgestimate/ethinyl oestradiol (250 microgram of norgestimate/35 microgram of ethinyl estradiol). Results of an open multicentre study of 59,701 women. Am J Obstet Gynecol 1992;166:1963-8.
22. Walling M. A multicentre efficacy and safety study of an oral contraceptive containing 150 μg desogestrel and 30 μg ethinyl oestradiol. Contraception 1992;46:313-26.
23. Brill K. Clinical experience with a modern dose gestodene containing oral contraceptive in adolescents. Adv Contracept 1994;1:237-47.
24. Rosenberg M. Weight changes with COC use and during the menstrual cycle. Contraception 1998;58:345-9.
25. Moore LL, Valucke R, McDougall C, et al. A comparative study of one-year weight gain among users of medroxy progesterone acetate, levonorgestrel implant and COCs. Contraception 1995;52:215-20.
26. Berenson AB, Weimann CM, Rickens V. Contraceptive outcomes among adolescents prescribed Norplant implants vs COC after one year of use. Am J Obstet Gynecol 1997;176:586-92.
27. Risser WL, Gefter LR, Barrat MS, et al. Weight changes in adolescents who used hormonal contraception. J Adol Health 1999;24: 433-6.
28. Reubinoff BE, Grubstein A, Meirow D, Berry E, Schenker JG, Brzezinski A. Effects of low-dose estrigen oral contraceptives on weight, body composition, and fat distribution in young women. Fertil Steril 1995;63:516-21.
29. Diffey B, Piers LS, Soares MJ, et al. The effect of oral contraceptive agents on the basal metabolic rate of young women. Br J Nutrition 1997;77:853-62.
30. Franchini M, Causco R, Nigrelli S. Evaluation of body composition during low dose oral contraceptive use. Acta Eur Fertil 1995;26: 69-73.
31. Goldzeiher JW, Moses LE, Averkin E, et al. A double-blind placebo controlled cross over investigaton of the side effects attributed to oral contraceptives. Fertil Steril 1971;22:609-22.
32. Neel EV, Litt LF, Jay MS. Side effects and compliance with low and conventional dose COC's among adolescents. J Adol Healthcare 1987;8:327-9.
33. Akerlund M, Rode A, Westergaard J, et al. Comparative profils of reliability, cycle control and side effects of 2 oral contraceptive formulations containing 150 μg desogestrel and either 30 or 20 μg ethinyl estradiol. Br J Obstet Gynaecol 1993:832-8.